📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells. (2018)

First Author: McCann AP

Attributed to: Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12964-018-0291-5

PubMed Identifier: 30409180

Publication URI: http://europepmc.org/abstract/MED/30409180

Type: Journal Article/Review

Volume: 16

Parent Publication: Cell communication and signaling : CCS

Issue: 1

ISSN: 1478-811X